Noncommunicable diseases: Three decades of global data show a mixture of increases and decreases in mortality rates

Health Affairs

Volumn 34, Issue 9, 2015, Pages 1444-1455

  Ali, Mohammed K ^a   Jaacks, Lindsay M ^a   Kowalski, Alysse J ^a   Siegel, Karen R ^a   Ezzati, Majid ^b  

^a EMORY UNIVERSITY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COLON CANCER; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; FEMALE; HEALTH CARE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; INCOME; INFANT; KNOWLEDGE; LIVER CANCER; LOWEST INCOME GROUP; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; MULTICENTER STUDY; NON COMMUNICABLE DISEASE; PREVENTION AND CONTROL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STOMACH CANCER; UTERINE CERVIX CANCER; CHRONIC DISEASE; HEALTH; NEOPLASM; PATHOPHYSIOLOGY; RESPIRATORY TRACT DISEASE; TIME FACTOR; TRENDS; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; GLOBAL HEALTH; HUMANS; MALE; MORTALITY; NEOPLASMS; RESPIRATORY TRACT DISEASES; TIME FACTORS; WORLD HEALTH ORGANIZATION;

EID: 84942306301     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2015.0570     Document Type: Article

References (61)

1. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, Levin-Rector A, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2071-94.
2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963): 117-71.
3. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859): 2197-223.
4. World Health Organization, World Bank. World report on disability [Internet]. Geneva: WHO; 2011 [cited 2015 Jul 17]. Available from: http://www.who.int/disabilities/world_report/2011/report.pdf
5. World Economic Forum. The global agenda 2009 [Internet]. Geneva: The Forum; 2009 [cited 2015 Jul 17]. Available from: http://www.weforum.org/pdf/globalagenda
6. World Health Organization. Noncommunicable diseases: fact sheet [Internet]. Geneva: WHO; [updated 2015 Jan; cited 2015 Jul 17]. Available from: http://www.who.int/mediacentre/factsheets/fs355/en/
7. World Health Organization. Health statistics and information systems: WHO Mortality Database [Internet]. Geneva: WHO; c 2015 [cited 2015 Jul 17]. Available from: http://www.who.int/healthinfo/mortality_data/en/
8. Mathers CD, Stevens GA, Boerma T, White RA, Tobias MI. Causes of international increases in older age life expectancy. Lancet. 2015;385(9967): 540-8.
9. United Nations Statistics Division. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings [Internet]. New York (NY): UN; [revised 2013 Oct 31; cited 2015 Jul 17]. Available from: http://unstats.un.org/unsd/methods/m49/m49regin.htm
10. World Bank. Country and lending groups [Internet]. Washington (DC): World Bank; c 2015 [2015 Jul 17]. Available from: http://data.worldbank.org/about/country-and-lending-groups
11. To access the Appendix, please click on the Appendix link in the box to the right of the article online.
12. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015; 372(14): 1333-41.
13. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014; 370(1): 60-8.
14. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493): 1267-78.
15. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005; 165(12): 1410-9.
16. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14): 1279-90.
17. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-86.
18. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356(23): 2388-98.
19. Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA. 2010;303(18): 1841-7.
20. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109(9): 1101-7.
21. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005; 162(8): 764-73.
22. Bandosz P, O'Flaherty M, Drygas W, Rutkowski M, Koziarek J, Wyrzykowski B, et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ. 2012; 344: d8136.
23. Unal B, Sözmen K, Arik H, Gerçeklioglu G, Altun D, Simsek H, et al. Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health. 2013; 13: 1135.
24. Di Cesare M, Bennett JE, Best N, Stevens GA, Danaei G, Ezzati M. The contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries. Int J Epidemiol. 2013;42(3): 838-48.
25. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet. 2011; 377(9765): 578-86.
26. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet. 2011; 377(9765): 568-77.
27. Imamura F, Micha R, Khatibzadeh S, Fahimi S, Shi P, Powles J, et al. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health. 2015;3(3):e132-42.
28. Ezzati M, Riboli E. Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med. 2013; 369(10): 954-64.
29. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859): 2224-60.
30. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994; 308(6925):367-72.
31. Holmes J, Meier PS, Booth A, Guo Y, Brennan A. The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses. Drug Alcohol Depend. 2012; 123(1-3): 7-14.
32. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001; (44 Suppl 2):S14-21.
33. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 2012; 35(6): 1252-7.
34. Gregg EW, Li Y, Wang J, Rios Burrows N, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014; 370(16): 1514-23.
35. McEwen LN, Karter AJ, Curb JD, Marrero DG, Crosson JC, Herman WH. Temporal trends in recording of diabetes on death certificates: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care. 2011;34(7): 1529-33.
36. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31-40.
37. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557-67.
38. Huffman MD, Lloyd-Jones DM, Ning H, Labarthe DR, Guzman Castillo M, O'Flaherty M, et al. Quantifying options for reducing coronary heart disease mortality by 2020. Circulation. 2013;127(25): 2477-84.
39. National Cancer Institute. Surveillance, Epidemiology, and End Results Program: SEER Stat Fact Sheets: breast cancer [Internet]. Bethesda (MD): NCI; [cited 2015 Jul 17]. Available from: http://seer.cancer.gov/statfacts/html/breast.html
40. Perez EA, Romond EH, Suman VJ, Jeong J-H, Sledge G, Geyer CE Jr, et al. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. J Clin Oncol. 2014;32(33): 3744-52.
41. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2positive breast cancer. N Engl J Med. 2005;353(16): 1673-84.
42. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in world regions. Lancet. 2012; 380(9856): 1840-50.
43. Gulland A. Uganda launches HPV vaccination programme to fight its commonest cancer. BMJ. 2012;345: e6055.
44. Shulman LN, Mpunga T, Tapela N, Wagner CM, Fadelu T, Binagwaho A. Bringing cancer care to the poor: experiences from Rwanda. Nat Rev Cancer. 2014;14(12): 815-21.
45. World Health Organization. Immunization coverage [Internet]. Geneva: WHO; [reviewed 2015 Apr; cited 2015 Jul 17]. (Fact Sheet No. 378). Available from: http://www.who.int/mediacentre/factsheets/fs378/en/
46. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5 Suppl 1):S5-S16.
47. Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105(5): 817-43.
48. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(8): 639-42.
49. Amiri M, Janssen F, Kunst AE. The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol. 2011;26(1): 23-8.
50. Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, et al. An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013. Jpn J Clin Oncol. 2015;45(4): 390-401.
51. Li WQ, Ma JL, Zhang L, Brown LM, Li JY, Shen L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014; 106(7).
52. Brownson RC, Fielding JE, Maylahn CM. Evidence-based public health: a fundamental concept for public health practice. Annu Rev Public Health. 2009;30(1): 175-201.
53. Australian Medical Association [Internet]. Kingston, Australia: AMA. Press release, Australian Government honoured for global leadership in tobacco control; 2012 May 25 [cited 2015 Jul 17]. Available from: https://ama.com.au/media/australian-government-honoured-global-leadership-tobacco-control
54. International Tobacco Control Policy Evaluation Project [Internet]. Waterloo (ON): ITC Policy Evaluation Project. Press release, Uruguay's tobacco control policies reducing smoking rates, encouraging quitting, finds six-year survey; 2014 Aug 20 [cited 2015 Jul 17]. Available from: http://www.itcproject.org/node/119
55. Kumar S, Mohanraj R, Sudha V, Wedick NM, Malik V, Hu FB, et al. Perceptions about varieties of brown rice: a qualitative study from Southern India. J Am Diet Assoc. 2011;111(10): 1517-22.
56. Draper CE, Davidowitz KJ, Goedecke JH. Perceptions relating to body size, weight loss, and weight-loss interventions in black South African women: a qualitative study. Public Health Nutr. 2015:1-9. [Epub ahead of print].
57. Martin A. The Chinese government is getting rich selling cigarettes. Bloomberg Business [serial on the Internet]. 2014 Dec 11 [cited 2015 Jul 20]. Available from: http://www.bloomberg.com/bw/articles/2014-12-11/the-chinese-government-is-getting-rich-selling-cigarettes
58. Roberto CA, Swinburn B, Hawkes C, Huang TT, Costa SA, Ashe M, et al. Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking. Lancet. 2015;385(9985): 2400-9.
59. Ackermann RT, Kenrik Duru O, Albu JB, Schmittdiel JA, Soumerai SB, Wharam JF, et al. Evaluating diabetes health policies using natural experiments: the Natural Experiments for Translation in Diabetes Study. Am J Prev Med. 2015;48(6): 747-54.
60. Ali MK, Rabadán-Diehl C, Flanigan J, Blanchard C, Narayan KM, Engelgau M. Systems and capacity to address noncommunicable diseases in low- and middle-income countries. Sci Transl Med. 2013;5(181): 181cm4.
61. Miller W, Rein D, O'Grady M, Yeung J-E, Eichner J, McMahon M. A review and analysis of economic models of prevention benefits [Internet]. Washington (DC): Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation; 2013 Apr [cited 2015 Jul 20]. Available from: http://aspe.hhs.gov/sp/reports/2013/economicmodels/rpt_economicmodels.cfm#_Toc335834561